Drug Profile
AVN 211
Alternative Names: AVN-211; CD-008-0173Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator ChemDiv
- Developer Avineuro Pharmaceuticals
- Class Antidementias; Antipsychotics; Pyrazoles; Pyrimidines; Small molecules
- Mechanism of Action Serotonin 6 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II/III Schizophrenia
- No development reported Alzheimer's disease
- Discontinued Anxiety disorders